Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Microbiology|August 30, 2018
The Role of Human Papillomaviruses and Polyomaviruses in BRAF-Inhibitor Induced Cutaneous Squamous Cell Carcinoma and Benign Squamoproliferative LesionsKarin J Purdie, Charlotte M Proby, Hasan Rizvi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 11, 2020
BMP-2 Signaling and Mechanotransduction Synergize to Drive Osteogenic Differentiation via YAP/TAZQiang Wei, Andrew Holle, Jie Li, et al.
International Journal of Molecular Sciences|July 25, 2019
A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic TestingSakinah Hassan, Karin J Purdie, Jun Wang, et al.
The Journal of Investigative Dermatology|February 15, 2013
Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanomaCristiana Lo Nigro, Hexiao Wang, Angela McHugh, et al.
Oncotarget|March 28, 2018
Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinomaAidan M Rose, Lindsay C Spender, Christopher Stephen, et al.
Nature Communications|January 14, 2017
TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signallingLiam A Hurst, Benjamin J Dunmore, Lu Long, et al.
EMBO Molecular Medicine|May 19, 2020
RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcomaHenry G Smith, Kunzah Jamal, Jasbani Hs Dayal, et al.
Nature Communications|September 12, 2018
The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signatureGareth J Inman, Jun Wang, Ai Nagano, et al.
Nature Communications|February 21, 2025
TGM6 is a helminth secretory product that mimics TGF-β binding to TGFBR2 to antagonize signaling in fibroblastsStephen E White, Tristin A Schwartze, Ananya Mukundan, et al.
Oncotarget|November 12, 2016
Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cellsLindsay C Spender, G John Ferguson, Sijia Liu, et al.
Pageof 7